Schizophrenia Trial, Recruiting NCT06036316 Sponsor: Centre Psychothérapique de Nancy Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT06036316
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For everyone in the study:

  • You are covered by a social security/health insurance scheme
  • You have been given full information about the study and agreed to take part by signing a consent form
  • If you are under 18, at least one parent or guardian has been informed about the study and has not objected to you taking part
  • Your first/native language is French

If you are in the "At-Risk or First Episode" group:

  • You are between 16 and 35 years old
  • You meet certain criteria for being at risk of psychosis or having had a first episode of psychosis, as measured by specific clinical assessment tools (confirm with trial site)

If you are in the "Schizophrenia" group:

  • You are between 16 and 55 years old
  • You have a diagnosis of schizophrenia according to standard psychiatric guidelines (DSM V)
  • You show specific signs of disorganised thinking or speech, as measured by a clinical rating scale (confirm with trial site)

If you are a healthy volunteer:

  • You are between 16 and 55 years old
  • If you are under 18, both parents or guardians have given permission for you to take part

Who may not be able to join:

For everyone:

  • You are currently pregnant, recently gave birth, or are breastfeeding
  • You are not free to make your own decisions due to a legal or court ruling
  • You are currently in a life-threatening emergency situation
  • You are an adult under a legal protection order such as guardianship or curatorship
  • You are an adult who is unable to give consent and has no legal protection measure in place
  • You have a condition that would make it very difficult for you to take part or understand what the study involves
  • You are currently dependent on or misusing substances (other than cannabis), based on standard psychiatric guidelines

If you are a healthy volunteer:

  • You have an ongoing psychiatric condition (excluding anxiety disorders), as measured by a specific clinical interview tool (confirm with trial site)
  • You show signs of a developmental disorder affecting spoken or written language, identified during a clinical examination

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Florent Bernardin, PhD, Centre psychothérapeutique de Nancy

Phone: 0383260863

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Psychothérapique de Nancy
Registry
ClinicalTrials.gov
Start date
23 January 2024
Est. completion
23 January 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

language assessment performance score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov